CollPlant Biotechnologies Ltd (NASDAQ: CLGN) Stock Information | RedChip

CollPlant Biotechnologies Ltd (NASDAQ: CLGN)


$3.6000
+0.1600 ( +4.65% ) 7.5K

CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives key revenue, Canada, Europe and Other, and Israel.

Market Data


Open


$3.6000

Previous close


$3.4400

Volume


7.5K

Market cap


$39.40M

Day range


$3.4650 - $3.5600

52 week range


$3.2400 - $6.9900

SEC Filings


Form Type Description Pages Date
6-k Form 6-K 4 Nov 27, 2024
6-k Form 6-K 1 Sep 25, 2024
6-k Form 6-K 3 Aug 20, 2024
6-k Form 6-K 53 Aug 20, 2024
6-k Form 6-K 4 Aug 19, 2024
6-k Form 6-K 3 Jul 29, 2024
6-k Form 6-K 3 Jun 06, 2024
6-k Form 6-K 3 May 29, 2024
6-k Form 6-K 3 Apr 04, 2024
20-f Annual reports 83 Apr 04, 2024

Latest News